Although
febrifugine (1) and
isofebrifugine (2),
alkaloids isolated from roots of the Dichroa febrifuga plant, show powerful
antimalarial activity against Plasmodium falciparum, strong side effects such as the
emetic effect have precluded their clinical use against
malaria. However, their
antimalarial potency makes them attractive substances as leads for developing new types of chemotherapeutic
antimalarial drugs. Thus, we have evaluated the in vitro
antimalarial activity of the analogues of
febrifugine (1) and
isofebrifugine (2). The activities of the analogues derived from Df-1 (3) and Df-2 (4), condensation products of 1 and 2 with
acetone, respectively, were also obtained. The 3' '-keto derivative (7, EC(50) = 2.0 x 10(-8) M) of 1 was found to exhibit potential
antimalarial activity with high selectivity against P. falciparum in vitro. The in vitro activities of the reduction product (8, EC(50) = 2.0 x 10(-8) M) of 1 at C-2' and its cyclic derivatives 9 and 10 (EC(50) = 3.7 x 10(-9) and 8.6 x 10(-9) M, respectively) were found to be strongly active and selective. Additionally, the Dess-Martin oxidation product of 3 was found to be strongly active with high selectivity against P. falciparum. A structure-activity relationship study (SAR) demonstrates that the essential role played by the
4-quinazolinone ring in the appearance of activity and the presence of a 1' '-amino group and C-2', C-3' ' O-functionalities are crucial in the activity of 1. For 7, 8, and 9, prepared as racemic forms, an in vivo study has also been conducted.